Showing results (101-110 of 212) with videos related to
Sort By:
Pageof 22
Psychoneuroendocrinology|October 23, 2012
Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategiesLaura W Harris, Paul C Guest, Matthew T Wayland, et al.Journal of Proteome Research|September 10, 2008
High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramidesEmanuel Schwarz, Sudhakaran Prabakaran, Phil Whitfield, et al.Molecular & Cellular Proteomics : MCP|March 20, 2008
Increased alpha-defensins as a blood marker for schizophrenia susceptibilityRachel M Craddock, Jeffrey T Huang, Edmund Jackson, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 28, 2012
Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patientsViktoria Stelzhammer, Paul C Guest, Matthias Rothermundt, et al.Proteomics. Clinical Applications|March 31, 2015
Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophreniaJulian A Jaros, Hassan Rahmoune, Hendrik Wesseling, et al.Proteomics|August 24, 2013
Development of a novel assay for proprotein converting enzyme activity on a multiplex bead-based array systemAndreas Albrecht, Hassan Rahmoune, Kristi Leedjärv, et al.Proteomics|May 4, 2011
Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometryDaniel Martins-de-Souza, Paul C Guest, Hannah Steeb, et al.NPJ Schizophrenia|June 24, 2016
The association between antibodies to neurotropic pathogens and schizophrenia: a case-control studyLot D de Witte, Hans C van Mierlo, Manja Litjens, et al.Translational Psychiatry|November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individualsSung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.Lancet (London, England)|February 7, 2002
Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression studySabine Bahn, Michael Mimmack, Margaret Ryan, et al.Pageof 22